PavanReddyMD

PubMed

• α1-Antitrypsin Infusion for treatment of Steroid Resistant Acute Graft-versus-Host Disease.
  Magenau, J. M.,Goldstein, S. C.,Peltier, D.,Soiffer, R. J.,Braun, T.,Pawarode, A.,Riwes, M. M.,Kennel, M.,Antin, J. H.,Cutler, C. S.,Ho, V. T.,Alyea, E. P.,Parkin, B. ...> ;Blood. 2018 Feb 14
• Vorinostat plus tacrolimus/methotrexate to prevent GVHD following myeloablative conditioning unrelated donor HCT.
  Choi, S. W.,Braun, T.,Henig, I.,Gatza, E.,Magenau, J.,Parkin, B.,Pawarode, A.,Riwes, M.,Yanik, G.,Dinarello, C. A.,Reddy, P.> ;Blood. 2017 Aug 09
• STAT3 Expression in Host Myeloid Cells Controls GVHD Severity.
  Nieves, E. C.,Toubai, T.,Peltier, D. C.,Oravecz-Wilson, K.,Liu, C.,Tamaki, H.,Sun, Y.,Reddy, P.> ;Biol. Blood Marrow Transplant.. 2017 Jul 12
• 3 citations
  Association of White Matter Lesions, Cerebral Atrophy, Intracranial Extravascular Calcifications, and Ventricular-Communicating Hydrocephalus with Delirium Among Veter...
  Mark B. Detweiler, Rathnakara M Sherigar, Geoffrey Bader, Kelly Sullivan, Arline Kenneth, Naciye Kalafat, Pavan Reddy, Brian Lutgens> ;Southern Medical Journal. 2017 Jun 1
• Tissue Tolerance: a distinct concept to control acute GVHD severity.
  Wu, S. R.,Reddy, P.> ;Blood. 2017 Feb 06
• Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
  Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu S, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, Sc...> ;Nat. Immunol.. 2016-09-20
• SAG/Rbx2-Dependent Neddylation Regulates T-cell Responses
  Pavan Reddy, MD> ;The American Journal of Pathology. 2016 Aug 21
• Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
  Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu S, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, Sc...> ;Nat. Immunol.. 2016-05-01
• Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
  Kitko CL, Braun T, Couriel DR, Choi SW, Connelly J, Hoffmann S, Goldstein S, Magenau J, Pawarode A, Reddy P, Schuler C, Yanik GA, Ferrara JL, Levine JE> ;Biol. Blood Marrow Transplant.. 2016-05-01
• Advances in understanding the pathogenesis of graft-versus-host disease.
  Magenau J, Runaas L, Reddy P> ;Br. J. Haematol.. 2016-04-01
• FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
  Song Y, Magenau J, Li Y, Braun T, Chang L, Bixby D, Hanauer DA, Chughtai KA, Gatza E, Couriel D, Goldstein S, Pawarode A, Reddy P, Riwes M, Connelly J, Harris A, Kitko...> ;Bone Marrow Transplant.. 2016-04-01
• Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.
  Toubai T, Mathewson ND, Magenau J, Reddy P> ;Front Immunol. 2016-01-01
• Acute Graft-versus-Host Disease: Novel Biological Insights.
  Teshima T, Reddy P, Zeiser R> ;Biol. Blood Marrow Transplant.. 2016-01-01
• Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A Universi...
  Pawarode A, Mineishi S, Reddy P, Braun TM, Khaled YA, Choi SW, Magenau JM, Harris AC, Connelly JA, Kitko CL, Parkin BL, Goldstein SC, Yanik GA, Levine JE, Ferrara JL, ...> ;Biol. Blood Marrow Transplant.. 2016-01-01
• Host CD8α+ dendritic cells may be a key factor for separating graft-versus-host disease from graft-versus-leukemia.
  Toubai T, Mathewson N, Oravecz-Wilson K, Reddy P> ;Biol. Blood Marrow Transplant.. 2015-04-01
• Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes.
  Gleimer M, Li Y, Chang L, Paczesny S, Hanauer DA, Frame DG, Byersdorfer CA, Reddy PR, Braun TM, Choi SW> ;Bone Marrow Transplant.. 2015-03-01
• Next generation treatment of acute graft-versus-host disease.
  Magenau J, Reddy P> ;Leukemia. 2014-12-01
• Current and emerging strategies for the prevention of graft-versus-host disease.
  Choi SW, Reddy P> ;Nat Rev Clin Oncol. 2014-09-01
• Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
  Gatza E, Braun T, Levine JE, Ferrara JLM, Zhao S, Wang T, Chang L, Harris A, Pawarode A, Kitko C, Magenau JM, Yanik GA, Couriel DR, Goldstein S, Connelly J, Reddy P, P...> ;Biol. Blood Marrow Transplant.. 2014-09-01
• Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.
  Chang L, Frame D, Braun T, Gatza E, Hanauer DA, Zhao S, Magenau JM, Schultz K, Tokala H, Ferrara JLM, Levine JE, Reddy P, Paczesny S, Choi SW> ;Biol. Blood Marrow Transplant.. 2014-09-01
• The difficulty in diagnosing cord colitis.
  Magenau J, Reddy P> ;Biol. Blood Marrow Transplant.. 2014-07-01
• The role of dendritic cells in graft-versus-tumor effect.
  Toubai T, Mathewson N, Reddy P> ;Front Immunol. 2014-01-01
• Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell ...
  Choi SW, Braun T, Chang L, Ferrara JLM, Pawarode A, Magenau JM, Hou G, Beumer JH, Levine JE, Goldstein S, Couriel DR, Stockerl-Goldstein K, Krijanovski OI, Kitko C, Ya...> ;Lancet Oncol.. 2014-01-01
• ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
  Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong C, Wang H, Chin A, Gomez A, Harris AC, Levine JE, Choi SW, Couriel D, Reddy P, Ferrara JLM, ...> ;N. Engl. J. Med.. 2013-08-08
• PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6.
  Sun Y, Sun J, Tomomi T, Nieves E, Mathewson N, Tamaki H, Evers R, Reddy P> ;J. Immunol.. 2013-04-15
• Join now to see all